Showing results (1141-1150 of 1,174) with videos related to

Sort By:
Pageof 118
International Journal of Radiation Oncology, Biology, Physics|October 16, 2025
Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial)Tian-You Zhan, Tao Zhang, Wen-Qing Wang, et al.
CA: a Cancer Journal for Clinicians|March 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 studyJian-Chun Duan, Jia Zhong, Bo-Yang Sun, et al.
Cancers|November 9, 2024
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and ImmunotherapyFyza Y Shaikh, Seoho Lee, James R White, et al.
Nature Medicine|September 8, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analysesJoshua E Reuss, Paul K Lee, Reza J Mehran, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2022
Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015)Yunpeng Wu, Xin Liu, Brandon S Imber, et al.
Molecular Cell|June 3, 2014
HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSαMu Zhang, Shengyan Xiang, Heui-Yun Joo, et al.
Nature Communications|June 10, 2026
Bioresorbable electrochemical sensors for continuous deep-tissue lactate monitoring in critical careChen Hu, Ruizhang Liang, Pengkai Li, et al.
Nature Communications|November 11, 2020
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencingGuan-Tian Lang, Yi-Zhou Jiang, Jin-Xiu Shi, et al.
Leukemia|September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) studyYong Yang, Ying Wang, Xin Liu, et al.
American Journal of Hematology|May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group studyShu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Pageof 118